Funds holding CADRENAL THERAPEUTICS INC
ISIN US1276362076 · United States
- Fund holders
- 7
- Of which ETFs
- 1 6 other funds
- Value held
- 257.2K $
- Share of capital
- 1.9 % of 3.6M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 33,278 | 111.1K $ | 0.93 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 16,859 | 56.3K $ | 0.00 % | 0.47 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 12,307 | 60.4K $ | 0.00 % | 0.34 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 2,449 | 12K $ | 0.07 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,041 | 10K $ | 0.06 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 1,109 | 5.4K $ | 0.03 % | as of May 31, 2026 ↗ | |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 914 | 1.8K $ | 0.00 % | 0.03 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 7 | -2 | 68,957 | +4.8 % |
| 2026Q2 | 9 | 0 | 65,829 | +9.6 % |
| 2026Q1 | 9 | -1 | 60,086 | -0.4 % |
| 2025Q4 | 10 | -1 | 60,330 | -7.5 % |
| 2025Q3 | 11 | +6 | 65,233 | +18.5 % |
| 2025Q2 | 5 | +1 | 55,033 | +412.8 % |
| 2025Q1 | 4 | +1 | 10,731 | +163.9 % |
| 2024Q4 | 3 | 4,067 |
Institutional managers
15 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 21,626 | 110.7K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 7,500 | 31.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,496 | 28.1K $ | as of Mar 31, 2026 |
| Cygnus Capital Advisors, LLC | 1,492 | 8 $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 393 | 2K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 300 | 1.5K $ | as of Mar 31, 2026 |
| Destiny Wealth Partners, LLC | 200 | 1K $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 150 | 768 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 100 | 512 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 99 | 507 $ | as of Mar 31, 2026 |
| Archer Investment Corp | 35 | 179 $ | as of Mar 31, 2026 |
| IFP Advisors, Inc | 30 | 154 $ | as of Mar 31, 2026 |
| UBS Group AG | 3 | 15 $ | as of Mar 31, 2026 |
| CURIO WEALTH, LLC | 1 | 5 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 5 $ | as of Mar 31, 2026 |
Declared shareholders of CADRENAL THERAPEUTICS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| The PNC Financial Services Group, Inc. | 8.13 % | 233,219 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding CADRENAL THERAPEUTICS INC". https://titelia.com/en/stocks/cadrenal-therapeutics-inc-US1276362076